2023

31/12/2023

December Newsletter 2023

20/12/2023

Chile deal opens wider American markets for Proteomics – The West Australian

19/12/2023

Promising health news, PromarkerEndo – ABC Perth Drive

18/12/2023

Endometriosis Diagnostic, PromarkerEndo – Channel 7 News Perth 4pm & 6pm

14/12/2023

Learning from UK’s kidney disease crisis – Medical Forum Magazine

23/11/2023

AGM Chairman’s Address and Investor Presentation

22/11/2023

The Perth health-tech company batting well above its average – 6PR Perth Radio, Money News

22/11/2023

Proteomics on a game-changing path to address kidney disease – AusBiz

22/11/2023

Proteomics nails US pricing milestone for diabetes test – The West Australian

16/11/2023

Bell Potter Healthcare Conference

30/10/2023

Investor Presentation – Non-deal Roadshow

20/10/2023

Chronic kidney disease with Dr Richard Lipscombe – Channel 9 News Perth 5pm bulletin

09/10/2023

As kidney disease reaches critical levels, doctors urge responsibility – 6PR Perth Radio

03/10/2023

Investor Webinar and Q&A session 3rd October 2023

29/09/2023

ASX Health Stocks: Proteomics soars 13pc after US sets price for PromarkerD – The Daily Telegraph

29/09/2023

US price locked in for Proteomics diabetes test – The West Australian

28/09/2023

Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener

27/09/2023

Proteomics develops new blood test for esophageal cancer – BioWorld

14/09/2023

Early diagnosis a step closer for those at risk of oesophageal cancer – BiotechDispatch

14/09/2023

Early detection for oesophageal cancer – Medical Forum

14/09/2023

Early Oesophageal Cancer Diagnosis Now Closer for At-Risk – Mirage News

12/09/2023

ISDE 19th World Congress for Esophageal Disease Presentation

10/09/2023

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented At Global Conference – Menafn

08/09/2023

Proteomics International (ASX:PIQ) to present new oesophageal cancer test at global conference – The Market Herald

08/09/2023

Proteomics blood test primed for cancer fight – The West Australian

04/09/2023

Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan – The West Australian

04/09/2023

Australasian Diabetes Congress Panel Discussion

25/07/2023

Bioshares Biotech Summit

15/06/2023

Intervention needed to stop kidney disease overwhelming NHS, Kidney Research UK says – Evening Standard

14/06/2023

NHS facing ‘impossible’ challenge to care for kidney disease patients, Kidney Research UK warns – itv

11/06/2023

Kidney disease ‘could become public health emergency’ without more funding, charity warns – sky news

06/06/2023

New Kidney Research UK Report Shows Kidney Disease is a Public Health Emergency

21/05/2023

Heartbreaking impact of endometriosis on women laid bare – The West Australian

18/05/2023

Video Interview – Exclusive Agreement with Sonic Healthcare USA

10/05/2023

Proteomics International & Sonic Healthcare USA sign exclusive licence agreement

10/05/2023

Proteomics seals exclusive deal for kidney test in US – The West Australian

10/05/2023

Proteomics International (ASX:PIQ) inks exclusive licence agreement to bring PromarkerD to the US market – The Market Herald

10/05/2023

Proteomics’ PromarkerD test enters the lucrative US market – THE SENTIMENT

10/05/2023

May Newsletter 2023

05/05/2023

New diagnostic blood test showcased at world’s premier endometriosis conference

03/05/2023

PromarkerD test scores show treatment with canagliflozin can lessen risk of diabetic kidney disease

26/04/2023

Clinical Advisory Board expanded to support PromarkerD USA and global rollout

26/04/2023

Proteomics boosts kidney test prospects with board gains – The West Australian

31/03/2023

Endometriosis Awareness Month: What women need to watch out for – THE CAROUSEL

24/03/2023

New blood test for Endometriosis offers improved early screening

24/03/2023

Proteomics reveals new blood test to identify endometriosis – The West Australian

17/03/2023

PromarkerD Application for Australian Medicare Benefits Schedule Listing & Investor Webinar

01/03/2023

Proteomics nears agreement to sell kidney disease test in USA – The West Australian

01/03/2023

US update: PromarkerD licensing negotiations

15/02/2023

Proteomics inks five-year extension to British distribution agreement – The West Australian

15/02/2023

Distribution agreement for PromarkerD in Britain extended

02/02/2023

Investor Presentation Euroz Hartleys Healthcare Forum

31/01/2023

January Newsletter 2023

03/01/2023

CPT PLA Reimbursement Code Approved in US for PromarkerD